Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

Ballard, Clive; Margallo‐Lana, Marisa; Juszczak, Edmund; Douglas, Simon; Swann, Alan; Thomas, Alan; T. O’Brien, John; Everratt, Anna; Sadler, Stuart; Maddison, Clare; Lee, Lesley; Bannister, Carol; Elvish, Ruth; Jacoby, Robin

doi:10.1136/bmj.38369.459988.8f

Public

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

Published in BMJ • Feb 18, 2005

Authors:

Clive Ballard

Marisa Margallo‐Lana

Edmund Juszczak

Abstract

OBJECTIVES: To determine the respective efficacy of quetiapine and rivastigmine for agitation in people with dementia in institutional care and to evaluate these treatments with respect to change in cognitive performance. DESIGN: Randomised double blind (clinician, patient, outcomes assessor) placeb...

Subject

Quetiapine

Rivastigmine

Placebo

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!